COMP <GO>
SKIN vs LNSR // ENTERPRISE SCALE & MARKET CAP
SkinHealth Systems Inc. (Class A) (NASDAQ) VS. LENSAR Inc. (NASDAQ) • 15-METRIC TALLY: SKIN 6
— LNSR 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: LNSR
LAST: $9.94 (-2.07%) • MKT CAP: $66.0M
market-cap
$66.0M
LAST: $5.84 (-2.18%) • MKT CAP: $73.3M
market-cap
$73.3M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SKIN VS. LNSR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SKIN | LNSR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 65.30% | 39.40% | +25.90 | SKIN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -26.90% | -35.00% | +8.10 | SKIN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -20.33% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -6.90% | -47.60% | +40.70 | SKIN | /operating-margins <GO> |
| Net Profit Margin | -3.20% | -60.00% | +56.80 | SKIN | /net-margins <GO> |
| Revenue Growth (YoY) | -10.00% | 12.40% | -22.40 | LNSR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | SKIN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.8 | 34.6 | +1.27 | SKIN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $66.0M | $73.3M | -$7.3M | LNSR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SKIN REV | LNSR REV | SKIN GROSS % | LNSR GROSS % | SKIN FCF | LNSR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $300.8M | $51.7M | 65.3% | 39.4% | $37.2M | -$14.9M |
| FY 2024 | $334.3M | $46.0M | 54.5% | 39.9% | $15.4M | -$2.4M |
| FY 2023 | $398.0M | $35.7M | — | — | $21.8M | -$9.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SKIN // BETA —
LNSR // BETA —